Skip to content

NEW peer reviewed evidence on the benefits of using CytoSorb Therapy in COVID-19 patients

presented by Dr. Volker Humbert

  • Continuous renal replacement therapy with the addition of CytoSorb cartridge in 50 critically ill patients with COVID-19 plus acute kidney injury: a case-series
  • Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia
Play Video

Share

|

NEW peer reviewed evidence on the benefits of using CytoSorb Therapy in COVID-19 patients

Play Video

Share

|

presented by Dr. Volker Humbert

  • Continuous renal replacement therapy with the addition of CytoSorb cartridge in 50 critically ill patients with COVID-19 plus acute kidney injury: a case-series
  • Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia

More Videos

Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
Webinar | CytoSorb therapy in COVID-19 patients
Webinar | CytoSorb therapy in COVID-19 patients
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.